Randomized comparison of 5 and 10 μg doses of two recombinant hepatitis B vaccines

Bryan, Joe P.; Craig, Peter G.; Reyes, Linda; Hakre, Shilpa; Jaramillo, Ruth; Harlan, Harold J.; MacArthy, Philip; Legters, Llewellyn J.

doi:10.1016/0264-410x(95)00030-5

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1997

2015

Publication Types

Select...

Article6

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 14 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This was not significantly different from that of the compared group whose anti-HBs seroconversion rate was 86.81%, which indicates that the immune effects of the different types of hepatitis B vaccines were consistent. These results are similar to those of Zhong (2009), Zhang et al (2010), and others (Bryan et al, 1995;Rendi-Wagner et al, 2001). Gong and Zhong (2009) used 10 µg of hepatitis B vaccine made by recombinant DNA techniques in Saccharomyces cerevisiae yeast by the Beijing Tiantan Company.…”

Section: Discussionsupporting

confidence: 79%